Research graph

Cited by

Admitted local publications that cite Efficacy and Safety of PD ‐1/ PD ‐ L1 Inhibitors Combined With Anti‐Angiogenic Tyrosine Kinase Inhibitors for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Systematic Review and Single‐Arm Meta‐Analysis.